Ultragenyx Pharmaceutical
RARE
#5301
Rank
S$2.11 B
Marketcap
S$20.73
Share price
-1.17%
Change (1 day)
-50.94%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2026 (TTM): S-$6.67

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is S-$6.69. In 2025 the company made an earnings per share (EPS) of S-$7.53 an increase over its 2024 EPS that were of S-$8.17.

EPS history for Ultragenyx Pharmaceutical from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$6.67-11.44%
2025S-$7.53-7.89%
2024S-$8.17-23.89%
2023S-$10.74-17.61%
2022S-$13.0350.67%
2021S-$8.65113.69%
2020S-$4.05-55.9%
2019S-$9.1882.56%
2018S-$5.03-45.15%
2017S-$9.1714.68%
2016S-$7.99
2014S-$2.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Lexicon Pharmaceuticals
LXRX
S-$0.18-97.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.02578-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S-$0.14-97.88%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S-$0.12-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA